Matthew Henn
Vermogen: 57 374 $ op 31-05-2026
Vermogen: 57 374 $ op 31-05-2026
Matthew R.
Henn is currently Director at The Microbiome Therapeutics Innovation Group and President & Chief Scientific Officer at Seres Therapeutics, Inc. Former roles include Director at Viral Genomics, Inc. and Director-Viral Genomics at The Broad Institute, Inc. from 2005 to 2012.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 7.838 ( 0,08% ) | 57 374 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SERES THERAPEUTICS, INC. | President | 02-03-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01-06-2012 |
Viral Genomics, Inc. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau